Indy RLT Financial Analyst at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, ManufacturingIndustries

Requirements

Bachelor’s degree in finance/accounting or relevant area
Minimum of 2 years’ experience in Finance
Experience in financial planning, forecasting, and reporting
Qualified applicants must be authorized to work in the United States on a full-time basis (Lilly will not provide support for or sponsor work authorization and/or visas for this role)

Responsibilities

Process accounting transactions in NetSuite (ERP system), ensuring accuracy and compliance with internal controls across all relevant financial activities, including processing invoices and journal entries, reconciling accounts, and supporting the month-end and year-end close processes as they pertain to the site
Partner with other site functions and other finance teams to ensure timely and accurate financial recording and reporting
Collaborate cross-functionally to resolve discrepancies, streamline processes, and uphold data integrity throughout all financial transactions
Ensure appropriate accounting and provide appropriate accounting direction on matters such as capital, liabilities, and prepaid assets
Support Sarbanes-Oxley (SOx) controls related requests from internal and external auditors
Partner with central finance teams to deliver corporate requests and support resolving issues as a part of the manufacturing finance team
Assist in various product costing initiatives as needed

Skills

NetSuite

ERP

Accounting

Journal Entries

Account Reconciliation

Month-End Close

Year-End Close

Financial Reporting

Sarbanes-Oxley

SOx Controls

Product Costing

Internal Controls

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free